Tharimmune, Inc. (THAR)
(Delayed Data from NSDQ)
$2.91 USD
-0.69 (-19.17%)
Updated Sep 22, 2025 04:00 PM ET
After-Market: $2.86 -0.05 (-1.72%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Tharimmune, Inc. has a market cap of $15.14M, which represents its share price of $2.66 multiplied by its outstanding shares number of 5.69M. As a small-cap company, THAR's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
THAR 2.91 -0.69(-19.17%)
Will THAR be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for THAR based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for THAR
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
Why MBX Biosciences Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket
Is THAR positioned for a breakout? 50 Day Moving Average Support shows up after soaring 35.34%
Is THAR primed for upward momentum? 50 Day Moving Average Support shows up after sliding 0.75%